These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32391234)

  • 1. A Hemodialysis Patient with Severe COVID-19 Pneumonia.
    Alalwan AA; Taher A; Alaradi AH
    Cureus; 2020 May; 12(5):e7995. PubMed ID: 32391234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019.
    Koshi E; Saito S; Okazaki M; Toyama Y; Ishimoto T; Kosugi T; Hiraiwa H; Jingushi N; Yamamoto T; Ozaki M; Goto Y; Numaguchi A; Miyagawa Y; Kato I; Tetsuka N; Yagi T; Maruyama S
    CEN Case Rep; 2021 Feb; 10(1):126-131. PubMed ID: 32940880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
    Gérard A; Romani S; Fresse A; Viard D; Parassol N; Granvuillemin A; Chouchana L; Rocher F; Drici MD;
    Therapie; 2020; 75(4):371-379. PubMed ID: 32418730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.
    Ferrey AJ; Choi G; Hanna RM; Chang Y; Tantisattamo E; Ivaturi K; Park E; Nguyen L; Wang B; Tonthat S; Rhee CM; Reddy U; Lau WL; Huang SS; Gohil S; Amin AN; Hsieh L; Cheng TT; Lee RA; Kalantar-Zadeh K
    Am J Nephrol; 2020; 51(5):337-342. PubMed ID: 32222713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.
    Jing R; Vunnam RR; Schnaubelt E; Vokoun C; Cushman-Vokoun A; Goldner D; Vunnam SR
    BMC Infect Dis; 2021 Jan; 21(1):68. PubMed ID: 33441085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in chronic hemodialysis patients: A report of 9 cases in Madrid, Spain.
    de la Flor Merino JC; Valga Amado F; Marschall A; Linares Grávalos T; Canepa-Escaro F; Ruiz Cícero E; Albarracín Sierra C; Gallegos Bayas G; Rodeles Del Pozo M
    Clin Nephrol; 2021 Jan; 95(1):45-53. PubMed ID: 33155542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia.
    Abe T; Izumo T; Ueda A; Hayashi M; Ishibashi Y
    CEN Case Rep; 2021 Feb; 10(1):42-45. PubMed ID: 32715376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.
    Maciorowski D; Idrissi SZE; Gupta Y; Medernach BJ; Burns MB; Becker DP; Durvasula R; Kempaiah P
    SLAS Discov; 2020 Dec; 25(10):1108-1122. PubMed ID: 32942923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
    Echarte-Morales J; Minguito-Carazo C; Del Castillo-García S; Borrego-Rodríguez J; Rodríguez-Santamarta M; Sánchez-Muñoz E; Bergel-García R; González-Maniega C; Prieto-González S; Menéndez-Suarez P; Tundidor-Sanz E; Benito-González T; Fernández-Vázquez F
    J Electrocardiol; 2021; 64():30-35. PubMed ID: 33307378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report.
    Huang L; Wang Y; Wang L; Lv Y; Liu Q
    Medicine (Baltimore); 2020 Jul; 99(27):e20956. PubMed ID: 32629703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Pneumonia in a Hemodialysis Patient.
    Tang B; Li S; Xiong Y; Tian M; Yu J; Xu L; Zhang L; Li Z; Ma J; Wen F; Feng Z; Liang X; Shi W; Liu S
    Kidney Med; 2020; 2(3):354-358. PubMed ID: 32292904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections.
    Purwati ; Budiono ; Rachman BE; Yulistiani ; Miatmoko A; Nasronudin ; Lardo S; Purnama YI; Laely M; Rochmad I; Ismail T; Wulandari S; Setyawan D; Rosyid AN; Setiawan HW; Wulaningrum PA; Asmarawati TP; Marfiani E; Yuniati SK; Fuadi MR; Endraswari PD; Purwaningsih ; Hendrianto E; Karsari D; Dinaryanti A; Ertanti N; Ihsan IS; Purnama DS; Indrayani Y
    Biochem Res Int; 2021; 2021():6685921. PubMed ID: 33628506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
    Diaz-Arocutipa C; Brañez-Condorena A; Hernandez AV
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):694-706. PubMed ID: 33772933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.
    Goicoechea M; Sánchez Cámara LA; Macías N; Muñoz de Morales A; Rojas ÁG; Bascuñana A; Arroyo D; Vega A; Abad S; Verde E; García Prieto AM; Verdalles Ú; Barbieri D; Delgado AF; Carbayo J; Mijaylova A; Acosta A; Melero R; Tejedor A; Benitez PR; Pérez de José A; Rodriguez Ferrero ML; Anaya F; Rengel M; Barraca D; Luño J; Aragoncillo I
    Kidney Int; 2020 Jul; 98(1):27-34. PubMed ID: 32437770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.
    Baralić K; Jorgovanović D; Živančević K; Antonijević Miljaković E; Antonijević B; Buha Djordjevic A; Ćurčić M; Đukić-Ćosić D
    Toxicol Appl Pharmacol; 2020 Nov; 406():115237. PubMed ID: 32920000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome.
    Gupta S; Madhyastha R; Hamed F; Balkis M; El Nekidy W; Attallah N
    Case Rep Nephrol; 2020; 2020():8829309. PubMed ID: 33299621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis.
    Lecronier M; Beurton A; Burrel S; Haudebourg L; Deleris R; Le Marec J; Virolle S; Nemlaghi S; Bureau C; Mora P; De Sarcus M; Clovet O; Duceau B; Grisot PH; Pari MH; Arzoine J; Clarac U; Boutolleau D; Raux M; Delemazure J; Faure M; Decavele M; Morawiec E; Mayaux J; Demoule A; Dres M
    Crit Care; 2020 Jul; 24(1):418. PubMed ID: 32653015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital.
    Gourieux B; Reisz F; Belmas AS; Danion F; Fourtage M; Nai T; Reiter-Schatz A; Ruch Y; Walther J; Nivoix Y; Michel B
    Eur J Hosp Pharm; 2021 Sep; 28(5):242-247. PubMed ID: 33239282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
    Zequn Z; Yujia W; Dingding Q; Jiangfang L
    Eur J Pharmacol; 2021 Feb; 893():173813. PubMed ID: 33345848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.